Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 6940-80-3 | MDL No. : | MFCD03840382 |
Formula : | C10H15NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PJXWCRXOPLGFLX-VIFPVBQESA-N |
M.W : | 165.23 | Pubchem ID : | 5356540 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.4 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 49.79 |
TPSA : | 32.26 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.4 cm/s |
Log Po/w (iLOGP) : | 2.29 |
Log Po/w (XLOGP3) : | 1.28 |
Log Po/w (WLOGP) : | 1.01 |
Log Po/w (MLOGP) : | 1.56 |
Log Po/w (SILICOS-IT) : | 1.74 |
Consensus Log Po/w : | 1.57 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.78 |
Solubility : | 2.76 mg/ml ; 0.0167 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.56 |
Solubility : | 4.58 mg/ml ; 0.0277 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.11 |
Solubility : | 0.128 mg/ml ; 0.000776 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.31 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | Stage #1: With magnesium sulfate In dichloromethane at 25℃; for 19 h; Stage #2: With sodium tetrahydroborate In methanol at 0 - 25℃; for 18 h; |
Step 1: (S)-Alininol (17.5 g, 233 mmol), PhCHO (26 g), and MgSO4 (70 g) were taken up in DCM and stirred at 25 0C for 19 h. The solution was filtered and concentrated which furnished a yellow solid. The residue was taken up in MeOH and cooled to O 0C. Sodium borohydride (11 g, 288 mmol) was added in portions to the solution at 0 0C (gas evolution). After the addition, the solution was stirred at 25 0C for 18 h. The solution was concentrated, and the residue was quenched carefully with 3 M HCI (aq.) (gas evolution/exotherm). The aqueous acidic layer was extracted with Et2O (4 X 200 ml_). The aqueous layer was cooled to 0 0C and made basic via addition of NaOH pellets (pH = 11 -12). The aqueous layer was extracted with DCM. The combined DCM layers were dried (MgSO4). Filtration and concentration gave 23.2 g (60percent) of the amino-alcohol as a white solid. |
[ 246232-73-5 ]
2-(Dibenzylamino)propane-1,3-diol
Similarity: 0.92
[ 101-98-4 ]
2-(Benzyl(methyl)amino)ethanol
Similarity: 0.86
[ 85817-34-1 ]
(4-Benzylpiperazin-2-yl)methanol
Similarity: 0.83
[ 246232-73-5 ]
2-(Dibenzylamino)propane-1,3-diol
Similarity: 0.92
[ 101-98-4 ]
2-(Benzyl(methyl)amino)ethanol
Similarity: 0.86
[ 62855-02-1 ]
(R)-(1,2,3,4-Tetrahydroisoquinolin-3-yl)methanol
Similarity: 0.83
[ 246232-73-5 ]
2-(Dibenzylamino)propane-1,3-diol
Similarity: 0.92
[ 101-98-4 ]
2-(Benzyl(methyl)amino)ethanol
Similarity: 0.86